# MAD Phase I Study to Investigate Contraloid Acetate

> **NCT03955380** · PHASE1 · COMPLETED · sponsor: **Prof. Dr. Dieter Willbold** · enrollment: 24 (actual)

## Conditions studied

- Alzheimer Dementia
- Alzheimer Disease

## Interventions

- **DRUG:** Contraloid

## Key facts

- **NCT ID:** NCT03955380
- **Lead sponsor:** Prof. Dr. Dieter Willbold
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-12
- **Primary completion:** 2019-04-03
- **Final completion:** 2019-04-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-05-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03955380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03955380, "MAD Phase I Study to Investigate Contraloid Acetate". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03955380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*